Ticker Scorecard - MCRB Basics Company: Seres Therapeutics, Inc. IPO Date: June 26, 2015 Sector: Healthcare Industry: Biotech Market Cap: $137.19M Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 3.63% Avg Daily Range (30 D): $0.02 | 3.02% Avg Daily Range (90 D): $0.03 | 4.35% Institutional Daily Volume Avg Daily Volume: 1.08M Avg Daily Volume (30 D): 1.25M Avg Daily Volume (90 D): 1.91M Trade Size Avg Trade Size (Sh.): 171 Avg Trade Size (Sh.) (30 D): 377 Avg Trade Size (Sh.) (90 D): 461 Institutional Trades Total Inst.Trades: 1,288 Avg Inst. Trade: $1.89M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $.66M Avg Inst. Trade Volume: .2M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.21M Avg Closing Trade (30 D): $.6M Avg Closing Trade (90 D): $.6M Avg Closing Volume: 251.79K     News Jan 16, 2025 @ 12:00 PM Seres Therapeutics Announces Receipt of Expected $... Source: N/A Jan 9, 2025 @ 12:00 PM Seres Therapeutics Announces New Translational Bio... Source: N/A Nov 22, 2024 @ 12:00 PM Seres Therapeutics to Participate in Piper Sandler... Source: Clear® Verified Oct 21, 2024 @ 5:00 PM Allogeneic Hematopoietic Stem Cell Transplant Mark... Source: Delveinsight Sep 26, 2024 @ 8:01 PM Seres Therapeutics Stockholders Approve Sale of VO... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.21 $.58 $-.22 Diluted EPS $-.21 $.58 $-.22 Revenue $ .06M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -25.48M $ 88.78M $ -32.87M Operating Income / Loss $ -42.39M $ -29.17M $ -31.35M Cost of Revenue $ $ $ Net Cash Flow $ -101.4M $ -4.41M $ -38.51M PE Ratio